If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

Share Price is delayed by 15 minutes
Get Live Data
66.50    0.00 (0.00%)
Bid:
66.00
Ask:
67.00
Spread: 1.00 (1.515%)
Market Cap: £80.67m
VLG Live PriceLast checked at - London Stock Exchange

Intraday Venture Life Share Chart

Director/PDMR Shareholding

17 Apr 2018 07:00

RNS Number : 0830L
Venture Life Group PLC
17 April 2018
 

Venture Life Group plc

 

("Venture Life" or "the Company")

 

Director/PDMR Shareholding

 

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market announces that, on 16 April 2018, Gianluca Braguti, a Director of the Company, transferred a total of 2.3 million ordinary shares of 0.3p each in the Company for nil consideration, subject to the terms of a lock-in deed as described below, to his two sons and his former wife (the 'Locked-in Parties'). Following the transaction, Gianluca Braguti's beneficial interest is 4,785,459 ordinary shares representing 13.0 per cent. of the Company's issued share capital.

 

The Locked-in Parties have agreed not to dispose of their holdings in the Company (the 'Locked-in Shares') for a period of 24 months commencing on the date when the relevant ordinary shares are registered in the name of a Locked-in Party (the 'Lock-in Period'). In addition, the Locked-in Parties have agreed to an orderly market arrangement whereby, following expiry of the Lock-in Period for as long as Gianluca Braguti is a Director of the Company, they will only dispose of their Locked-in Shares via the Company's broker. The Locked-In Parties have also agreed that, for as long as Gianluca Braguti is a Director of the Company, all voting rights attached to their Locked-in Shares will be exercised as directed by him. 

 

 

 

 

Enquiries

 

Venture Life Group PLC

+44 (0) 1344 578 004

Jerry Randall, Chief Executive Officer

 

Adrian Crockett, Chief Financial Officer

 

 

Northland Capital Partners Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3861 6625

Matthew Johnson/Edward Hutton (Corporate Finance)

 

Bob Pountney (Corporate Broking)

 

 

 

Turner Pope Investments (TPI) Ltd (Joint Broker)

+44 (0) 20 3621 4120

Andy Thacker

 

 

 

Walbrook PR

venturelife@walbrookpr.com or +44 (0) 20 7933 8780

Paul McManus/Anna Dunphy

+44 (0) 7980 541 893 / +44 (0) 7876 741 001

   

 

 

 

 

 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Name

Gianluca Braguti

 

2

 

Reason for the notification

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Venture Life Group plc

b)

 

LEI

 213800S8CZUPLAB2KC70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of 0.3p each in Venture Life Group plc

b)

Identification code 

 

GB00BFPM8908

c)

 

Nature of the transaction 

 

Disposal 

d)

 

Price and volumes

Price: nil consideration

Volumes: 2.3 million Ordinary Shares

d)

 

Aggregated information 

- Aggregated volume

- Price

 N/a

 

e)

 

Date of the transaction 

16 April 2018

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFSESRIRLIT
Date   Source Headline
9th Jul 20267:00 amRNSTransaction in Own Shares
2nd Jul 20268:00 amRNSTotal Voting Rights
30th Jun 20263:03 pmRNSDirector/PDMR Shareholding
30th Jun 20267:00 amRNSFull Year Trading Update
24th Jun 20268:25 amRNSTransaction in Own Shares
23rd Jun 20267:00 amRNSTransaction in Own Shares
22nd Jun 20267:00 amRNSTransaction in Own Shares
19th Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNSAcquisition of FemiClear and CUROXEN
1st May 20262:39 pmRNSHolding(s) in Company
1st Apr 20264:30 pmRNSTotal Voting Rights
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSInterim Results
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20269:33 amRNSInvestor Presentation via Investor Meet Company
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20262:11 pmRNSGrant of Options and Director Dealing
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:31 pmRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.